Promising brain cancer trial given breakthrough status by FDA
This may be one of the most important news articles of the year. This will give the trial the green light to start all over the country - and if successful, may quickly lead to FDA approval. There will be a story about this treatment on "60 Minutes" on Sunday.
Disclaimer - I am on the patient advisory board of The Brain Tumor Center at Duke, but have no financial interest in it.
